Follistatin 315
Activin-Binding Protein, FSH-Suppressing Protein, FST-315, FS-315
Follistatin-315 is the predominant circulating isoform of follistatin, a glycoprotein that binds and neutralizes TGF-β family members like myostatin and activin to promote muscle growth and regulate various physiological processes.
Completed
PHASE1, PHASE2
NCT02964377
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
Craig McDonald, MD
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT04203212
BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH
424 General Military Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NA
NCT04112875
Effect of L-arginine on Microcirculation, Myogenesis and Angiogenesis Associated With Aging, Sarcopenia and Diabetes
Rio de Janeiro State University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT03050944
Association of the Mediterranean Diet With Fertility Outcomes
Harokopio University
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT01856868
Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
Craig McDonald, MD
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT02070198
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
Bioroma
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT02895178
Lifestyles Of Health And Sustainability for Breast Cancer Survivors
Wonju Severance Christian Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
NA
NCT07005193
Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health
Huazhong University of Science and Technology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04736602
Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.
Ipsen
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06359444
Effect of High Intensity Exercise Rehabilitation on Liver Function and Insulin Sensitivity in Patients With MASLD
University Ghent
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT06229899
Follistatin Levels in Metabolically Healthy and Unhealthy Obese Individuals
Goztepe Prof Dr Suleyman Yalcın City Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT01519349
Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
Nationwide Children's Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05632484
Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia
Hospices Civils de Lyon
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT06411366
Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans
Minicircle
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT02993926
A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants
Takeda
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NA
NCT04907721
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis
University of Copenhagen
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT03986684
Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
Hippocration General Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT04386304
Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy
Epirium Bio Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
EARLY PHASE1
NCT00734279
Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
University of Utah
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT04899193
Pergoveris FD and Liquid China BE Study
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
INTERVENTIONAL
Updated Dec 15, 2025